These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8628043)

  • 21. The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials. Swiss Group for Clinical Cancer Research (SAKK) and the International Breast Cancer Study Group (IBCSG).
    Hürny C; Bernhard J; Bacchi M; van Wegberg B; Tomamichel M; Spek U; Coates A; Castiglione M; Goldhirsch A; Senn HJ
    Support Care Cancer; 1993 Jul; 1(4):200-8. PubMed ID: 8193882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cancer Worry Scale: detecting fear of recurrence in breast cancer survivors.
    Custers JA; van den Berg SW; van Laarhoven HW; Bleiker EM; Gielissen MF; Prins JB
    Cancer Nurs; 2014; 37(1):E44-50. PubMed ID: 23448956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
    Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
    BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between socioeconomic status and altered appearance distress, body image, and quality of life among breast cancer patients.
    Chang O; Choi EK; Kim IR; Nam SJ; Lee JE; Lee SK; Im YH; Park YH; Cho J
    Asian Pac J Cancer Prev; 2014; 15(20):8607-12. PubMed ID: 25374176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life studies of the Australian New Zealand Breast Cancer Trials Group: approaches to missing data.
    Coates A; Gebski V
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):533-40. PubMed ID: 9549802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life is improved in breast cancer patients by Standardised Mistletoe Extract PS76A2 during chemotherapy and follow-up: a randomised, placebo-controlled, double-blind, multicentre clinical trial.
    Semiglazov VF; Stepula VV; Dudov A; Schnitker J; Mengs U
    Anticancer Res; 2006; 26(2B):1519-29. PubMed ID: 16619567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation study of a quality of life (QOL) questionnaire for use in Iran.
    Safaee A; Moghim Dehkordi B
    Asian Pac J Cancer Prev; 2007; 8(4):543-6. PubMed ID: 18260726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial.
    Ganz PA; Kwan L; Stanton AL; Krupnick JL; Rowland JH; Meyerowitz BE; Bower JE; Belin TR
    J Natl Cancer Inst; 2004 Mar; 96(5):376-87. PubMed ID: 14996859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.
    Tormey DC; Gray R; Falkson HC
    J Natl Cancer Inst; 1996 Dec; 88(24):1828-33. PubMed ID: 8961972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study protocol of the CAREST-trial: a randomised controlled trial on the (cost-) effectiveness of a CBT-based online self-help training for fear of cancer recurrence in women with curatively treated breast cancer.
    van Helmondt SJ; van der Lee ML; de Vries J
    BMC Cancer; 2016 Jul; 16():527. PubMed ID: 27455846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
    Foukakis T; von Minckwitz G; Bengtsson NO; Brandberg Y; Wallberg B; Fornander T; Mlineritsch B; Schmatloch S; Singer CF; Steger G; Egle D; Karlsson E; Carlsson L; Loibl S; Untch M; Hellström M; Johansson H; Anderson H; Malmström P; Gnant M; Greil R; Möbus V; Bergh J;
    JAMA; 2016 Nov; 316(18):1888-1896. PubMed ID: 27825007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The OnyCOE-t questionnaire: responsiveness and clinical meaningfulness of a patient-reported outcomes questionnaire for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Tavakkol A
    Health Qual Life Outcomes; 2006 Aug; 4():50. PubMed ID: 16911778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
    Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
    J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life?
    de Boer AG; van Lanschot JJ; Stalmeier PF; van Sandick JW; Hulscher JB; de Haes JC; Sprangers MA
    Qual Life Res; 2004 Mar; 13(2):311-20. PubMed ID: 15085903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-related quality of life, psychological distress, and adverse events in postmenopausal women with breast cancer who receive tamoxifen, exemestane, or anastrozole as adjuvant endocrine therapy: National Surgical Adjuvant Study of Breast Cancer 04 (N-SAS BC 04).
    Takei H; Ohsumi S; Shimozuma K; Takehara M; Suemasu K; Ohashi Y; Hozumi Y
    Breast Cancer Res Treat; 2012 May; 133(1):227-36. PubMed ID: 22234519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
    Jahanzeb M
    Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
    Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
    Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life and psychological distress during neoadjuvant endocrine therapy with letrozole to determine endocrine responsiveness in postmenopausal breast cancer.
    Taira N; Iwata H; Hasegawa Y; Sakai T; Higaki K; Kihara K; Yamaguchi T; Ohsumi S; Shimozuma K; Ohashi Y
    Breast Cancer Res Treat; 2014 May; 145(1):155-64. PubMed ID: 24692082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.